Is a boost dose essential in breast conserving therapy? An EORTC phase III study (22881/10882)

C. Vrieling; J.C. Horiot; E. van der Schueren; P. Poortmans; H. Struikmans; L. Collette; M. Pierart; H. Bartelink

Is a boost dose essential in breast conserving therapy? An EORTC phase III study (22881/10882)

C. Vrieling
, J.C. Horiot
, E. van der Schueren
, P. Poortmans
, H. Struikmans
, L. Collette
, M. Pierart
, H. Bartelink

Utrecht University

extern
University Medical Center Utrecht

Research output: Chapter in Book/Report/Conference proceeding › Conference contribution › Academic › peer-review

Original language	Undefined/Unknown
Title of host publication	Proceedings 8th Varian European Users Meeting, Vilamoura, Portugal, 27-30 April
Pages	8-10
Number of pages	3
Publication status	Published - 1997

Cite this

@inproceedings{8749da9760614bb2bb00328c93919b31,

title = "Is a boost dose essential in breast conserving therapy? An EORTC phase III study (22881/10882)",

author = "C. Vrieling and J.C. Horiot and \{van der Schueren\}, E. and P. Poortmans and H. Struikmans and L. Collette and M. Pierart and H. Bartelink",

year = "1997",

language = "Undefined/Unknown",

pages = "8--10",

booktitle = "Proceedings 8th Varian European Users Meeting, Vilamoura, Portugal, 27-30 April",

}

TY - GEN

T1 - Is a boost dose essential in breast conserving therapy? An EORTC phase III study (22881/10882)

AU - Vrieling, C.

AU - Horiot, J.C.

AU - van der Schueren, E.

AU - Poortmans, P.

AU - Struikmans, H.

AU - Collette, L.

AU - Pierart, M.

AU - Bartelink, H.

PY - 1997

Y1 - 1997

M3 - Conference contribution

SP - 8

EP - 10

BT - Proceedings 8th Varian European Users Meeting, Vilamoura, Portugal, 27-30 April

ER -